Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: HOG GU12-160 Principal Investigator: Picus, Joel
Title: A Randomized Phase 2 Study Comparing Docetaxel Alone to Docetaxel in Combination with OGX-427 in Patients with Relapsed or Refractory Metastatic Urothelial Carcinoma after Receiving a Platinum-containing Regimen
Description: The purpose of this study is to evaluate whether the combination of OGX-427 plus docetaxel will prolong the survival time of compared to docetaxel alone in patients with urothelial cancer whom are no longer responding to platinum-based chemotherapy treatment....MORE
___________________________________________________________________________________________________
 Number: SWOG S1314 Principal Investigator: Picus, Joel
Title: A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer
Description: The primary focus of this study is to see if looking at tumor biomarkers using a program called “coexpression extrapolation or COXEN” may predict a patient's response to chemotherapy before surgery....MORE
___________________________________________________________________________________________________
 Number: RTOG 0926 Principal Investigator: Gay, Hiram
Title: A Phase II Protocol for Patients with Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent with Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging
Description: The purpose of this study is to find out the effects of transurethal surgery followed by radiation therapy plus chemotherapy....MORE
___________________________________________________________________________________________________
 Number: CTSU S1011 Principal Investigator: Grubb, III, Robert
Title: A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed At Time of Radial Cystectomy For Muscle Invasive Urothelial Cancer
Description: The purpose of this study is to compare the effects, good and/or bad, of performing a standard lymph node removal versus an extended lymph node removal for patients with muscle invasive urothelial cancer....MORE
___________________________________________________________________________________________________
 Number: CALGB 90601 Principal Investigator: Picus, Joel
Title: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, And Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma
Description: The purpose of this study is to compare the effects, good and/or bad, of the combination of the chemotherapy drugs gemcitabine and cisplatin with the combination of gemcitabine, cisplatin, and the experimental drug bevacizumab on transitional cell cancer to find out which is better....MORE
___________________________________________________________________________________________________
 Number: 201306061 Principal Investigator: Picus, Joel
Title: A Phase Ib/II Trial of ALT-801 in Combination with Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Description: The purpose of this research study is to find out what are the side effects of the study drugs, ALT-801, plus gemcitabine with or without cisplatin, in patients with bladder cancer....MORE
___________________________________________________________________________________________________
 Number: 201306057 Principal Investigator: Picus, Joel
Title: A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS15E Given as Monotherapy in Subjects with Metastatic Urothelial Cancer
Description: The main purpose is to determine a safe dose of an invesigational drug, AGS15E, by testing the drug at different dose levels. The study will find out what effects, good and/or bad, it has on patients and their cancer....MORE
___________________________________________________________________________________________________